Katrina J. Church - Apr 1, 2022 Form 4/A - Amendment Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Apr 1, 2022
Transactions value $
-$1,007
Form type
4/A - Amendment
Date filed
6/8/2023, 08:05 PM
Date Of Original Report
Apr 21, 2023
Previous filing
Apr 12, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Sale -$211 -15 -0.14% $14.07 10.3K Apr 1, 2022 Direct F1
transaction BVS Class A Common Stock Sale -$390 -58 -0.56% $6.73 10.3K Jul 1, 2022 Direct F1
transaction BVS Class A Common Stock Sale -$406 -58 -0.56% $7.00 10.2K Oct 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes in connection with purchases made under the Company's 2021 Employee Stock Purchase Plan and a Rule 10b5-1 instruction in place at the time of such purchases.

Remarks:

The Form 4/A is being filed to uncheck the Rule 10b5-1(c) Transaction Indication box that was previously inadvertently checked.